Cargando…
A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer
Background: Current staging systems are inadequate for evaluating the prognosis of patients with locally advanced gastric cancer (LAGC, stages II–III). Therefore, we developed a serum microRNA (miRNA) signature to facilitate individualized management of these patients. Methods: Using microarray anal...
Autores principales: | Chen, Shangxiang, Lao, Jiawen, Geng, Qirong, Zhang, Ji, Wu, Aiwen, Xu, Dazhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323914/ https://www.ncbi.nlm.nih.gov/pubmed/32656071 http://dx.doi.org/10.3389/fonc.2020.00565 |
Ejemplares similares
-
ASTE1 frameshift mutation triggers the immune response in Epstein-Barr virus-associated gastric cancer
por: Huang, Binhao, et al.
Publicado: (2022) -
Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection
por: Liu, Jianjun, et al.
Publicado: (2017) -
Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy
por: Liu, Jianjun, et al.
Publicado: (2016) -
MicroRNA Signature in Renal Cell Carcinoma
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2020) -
MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)